Although the precise reasons for these differences remain currently unclear, they may be related to the specific microenvironment provided by lung TILs in NSCLC or to the question whether the targeted tumor cell type expresses the IL-9R. The gene discussed is IL9R; the disease is non-small cell lung carcinoma.